Total Payments
$1,999
2021 Payments
$614.64
Companies
24
Transactions
115
Medicare Patients
4,791
Medicare Billing
$357,165
Payment Breakdown by Category
Food & Beverage$1,999 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,999 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $628.96 | 42 | $0 (2021) |
| Esperion Therapeutics, Inc. | $218.05 | 15 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $184.47 | 12 | $0 (2021) |
| Akcea Therapeutics, Inc. | $171.61 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $105.23 | 6 | $0 (2018) |
| Bardy Diagnostics, Inc. | $70.00 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $68.05 | 5 | $0 (2021) |
| GE HEALTHCARE | $61.28 | 1 | $0 (2019) |
| Amarin Pharma Inc. | $60.75 | 4 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $52.11 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $614.64 | 33 | Esperion Therapeutics, Inc. ($162.22) |
| 2020 | $169.74 | 11 | Esperion Therapeutics, Inc. ($55.83) |
| 2019 | $500.79 | 27 | Amgen Inc. ($186.33) |
| 2018 | $338.02 | 22 | Amgen Inc. ($100.06) |
| 2017 | $376.13 | 22 | Amgen Inc. ($230.03) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/21/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiology | ||||||
| 09/14/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/31/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/25/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiology | ||||||
| 08/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/03/2021 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/27/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/22/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology | ||||||
| 06/30/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiology | ||||||
| 06/29/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/23/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiovascular | ||||||
| 05/20/2021 | Medtronic, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/19/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/18/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Cardiology | ||||||
| 05/17/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology | ||||||
| 05/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Diabetes | ||||||
| 04/22/2021 | Medtronic, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Transcatheter Valve Systems | ||||||
| 04/21/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2021 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 14 | 2,281 | 2,709 | $676,322 | $178,504 |
| 2020 | 14 | 2,510 | 2,942 | $723,572 | $178,661 |
Total Patients
4,791
Total Services
5,651
Medicare Billing
$357,165
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 434 | 462 | $369,600 | $69,048 | 18.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 337 | 435 | $95,700 | $43,522 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 439 | 470 | $70,500 | $30,258 | 42.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 691 | 911 | $42,817 | $9,572 | 22.4% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 48 | 48 | $38,400 | $8,636 | 22.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $11,390 | $4,454 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 77 | $11,550 | $4,407 | 38.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 35 | 38 | $7,790 | $2,793 | 35.8% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2021 | 48 | 48 | $9,120 | $2,068 | 22.7% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Office | 2021 | 48 | 48 | $9,120 | $983.52 | 10.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,860 | $903.20 | 31.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 37 | 41 | $3,485 | $738.40 | 21.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2021 | 40 | 42 | $2,310 | $663.34 | 28.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2021 | 40 | 42 | $1,680 | $457.50 | 27.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 450 | 476 | $380,800 | $71,167 | 18.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 549 | 593 | $88,950 | $30,786 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 274 | 325 | $71,500 | $26,694 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 55 | 204 | $30,600 | $11,998 | 39.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 742 | 891 | $41,877 | $10,643 | 25.4% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2020 | 55 | 56 | $44,800 | $8,596 | 19.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $13,400 | $4,816 | 35.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 55 | 55 | $12,100 | $4,437 | 36.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 33 | 35 | $7,175 | $2,735 | 38.1% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2020 | 51 | 52 | $9,880 | $2,268 | 23.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 18 | 19 | $4,465 | $1,086 | 24.3% |
About Dr. Stephen Lenhoff, MD
Dr. Stephen Lenhoff, MD is a Cardiovascular Disease healthcare provider based in Arlington, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477517456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Lenhoff, MD has received a total of $1,999 in payments from pharmaceutical and medical device companies, with $614.64 received in 2021. These payments were reported across 115 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,999).
As a Medicare-enrolled provider, Lenhoff has provided services to 4,791 Medicare beneficiaries, totaling 5,651 services with total Medicare billing of $357,165. Data is available for 2 years (2020–2021), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Arlington, TX
- Active Since 04/14/2006
- Last Updated 09/15/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477517456
Products in Payments
- Corlanor (Drug) $337.84
- Repatha (Biological) $291.12
- NEXLETOL (Drug) $197.34
- TEGSEDI (Drug) $171.61
- ENTRESTO (Drug) $105.23
- PRALUENT (Drug) $104.17
- MULTAQ (Drug) $80.30
- Carnation Ambulatory Monitor (Device) $70.00
- XARELTO (Drug) $68.05
- Vascepa (Drug) $60.75
- CoreValve Evolut (Device) $55.73
- UPTRAVI (Drug) $52.11
- ELIQUIS (Drug) $44.83
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $36.31
- FLEXITOUCH (Device) $27.10
- PRALUENT ALIROCUMAB INJECTION (Biological) $24.07
- Ozempic (Drug) $24.02
- NEXLIZET (Drug) $20.71
- JARDIANCE (Drug) $19.74
- ZONTIVITY (Drug) $17.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Arlington
Dr. Stuart Lander, Md, MD
Cardiovascular Disease — Payments: $69,834
Cardiovascular Disease $69,834
Dr. Richard Perrin, Md, MD
Cardiovascular Disease — Payments: $21,632
Cardiovascular Disease $21,632
Aref Obagi, M.d, M.D
Cardiovascular Disease — Payments: $13,403
Cardiovascular Disease $13,403
Charanjit Khurana, Md, MD
Cardiovascular Disease — Payments: $13,403
Cardiovascular Disease $13,403
Edward Howard
Cardiovascular Disease — Payments: $12,651
Cardiovascular Disease $12,651
Dr. Aditi Bhagat, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $12,088
Cardiovascular Disease $12,088